KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Long-Term Investments (2022 - 2024)

Staar Surgical (STAA) has disclosed Long-Term Investments for 3 consecutive years, with $265000.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Long-Term Investments fell 98.49% year-over-year to $265000.0, compared with a TTM value of $265000.0 through Jun 2024, down 98.49%, and an annual FY2023 reading of $11.7 million, down 15.82% over the prior year.
  • Long-Term Investments was $265000.0 for Q2 2024 at Staar Surgical, down from $7.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $17.5 million in Q2 2023 and bottomed at $265000.0 in Q2 2024.
  • Average Long-Term Investments over 3 years is $11.3 million, with a median of $13.4 million recorded in 2022.
  • The sharpest move saw Long-Term Investments rose 2.0% in 2023, then crashed 98.49% in 2024.
  • Year by year, Long-Term Investments stood at $13.9 million in 2022, then dropped by 15.82% to $11.7 million in 2023, then crashed by 97.74% to $265000.0 in 2024.
  • Business Quant data shows Long-Term Investments for STAA at $265000.0 in Q2 2024, $7.0 million in Q1 2024, and $11.7 million in Q4 2023.